Henry Schein acquires substantially all assets of Lincoln Dental Supply

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, this week announced the acquisition of substantially all assets of Lincoln Dental Supply from Keystone Industries, a worldwide leader and privately held group of dental, medical and veterinary manufacturing and distribution subsidiaries.

Lincoln Dental Supply will become part of Zahn Dental, Henry Schein's dental laboratory distribution business. Zahn is a leading distributor to dental laboratories in North America.

Founded in 1909 and headquartered in Cherry Hill, N.J., Lincoln Dental Supply offers a wide range of dental products and equipment to dental laboratories within the United States and Canada. The company distributes branded products as well as Keystone's private-label line. In 2013, Lincoln Dental Supply had sales of approximately $18 million. Financial terms of the transaction were not disclosed. 

"Lincoln Dental Supply is an excellent fit with our Zahn Dental business as each organization enjoys a long and highly respected history of serving dental laboratories," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "By combining these two leading companies, we further strengthen Zahn's presence in the North America dental laboratory market and expand our product offering in the important prosthetic segment of this business."

"We are very pleased to join Zahn Dental, a clear leader in the dental laboratory market," said Jeff DiBlasi, Vice President, Lincoln Dental Supply. "We look forward to our customers benefiting from the global resources we will provide as part of the Henry Schein family and to sharing best practices with our new colleagues."

Cautionary Note from Henry Schein Regarding Forward-Looking Statements?In accordance with the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements are identified by the use of such terms as "may," "could," "expect," "intend," "believe," "plan," "estimate," "forecast," "project," "anticipate" or other comparable terms. A full discussion of our operations and financial condition, including factors that may affect our business and future prospects, is contained in documents we have filed with the SEC and will be contained in all subsequent periodic filings we make with the SEC. These documents identify in detail important risk factors that could cause our actual performance to differ materially from current expectations.

Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: effects of a highly competitive market; our dependence on third parties for the manufacture and supply of our products; our dependence upon sales personnel, customers, suppliers and manufacturers; our dependence on our senior management; fluctuations in quarterly earnings; risks from expansion of customer purchasing power and multi-tiered costing structures; possible increases in the cost of shipping our products or other service issues with our third-party shippers; general global macro-economic conditions; disruptions in financial markets; possible volatility of the market price of our common stock; changes in the health care industry; implementation of health care laws; failure to comply with regulatory requirements and data privacy laws; risks associated with our global operations; transitional challenges associated with acquisitions and joint ventures, including the failure to achieve anticipated synergies; financial risks associated with acquisitions and joint ventures; litigation risks; the dependence on our continued product development, technical support and successful marketing in the technology segment; risks from rapid technological change; risks from disruption to our information systems; certain provisions in our governing documents that may discourage third-party acquisitions of us; and changes in tax legislation. The order in which these factors appear should not be construed to indicate their relative importance or priority. 

We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.